Literature DB >> 7705829

An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.

Q Zeng1, M Dammerman, Y Takada, A Matsunaga, J L Breslow, J Sasaki.   

Abstract

Polymorphisms and haplotypes at the adjacent apolipoprotein (apo) AI and CIII gene loci were investigated in 61 Japanese patients with triglycerides greater than 350 mg/dl and in 66 unrelated normolipidemic subjects. The polymorphic sites were the SstI site in the apoCIII 3' untranslated region, whose presence has previously been shown to be associated with hypertriglyceridemia (HTG) in Caucasians, and the MspI site in the third intron of the apoAI gene. The frequencies of the SstI minor allele (S2) were 0.48 in HTG patients and 0.25 in normolipidemic subjects (P < 0.00015). The frequencies of the MspI minor allele (M2) were 0.61 in HTG patients and 0.33 in normolipidemic subjects (P < 0.00001). The two polymorphic sites were in strong linkage disequilibrium, and maximum likelihood analysis supported the existence of three of the four possible haplotypes: S1-M1, S1-M2, and S2-M2. Since all S2 alleles were estimated to be present on M2-bearing chromosomes, the HTG-associated S2-M2 haplotype conferred the same approximate relative risk as the S2 allele alone when compared with the other two haplotypes (odds ratio 2.8). This study demonstrates that the S2 allele is a marker for HTG among west Japanese subjects as well as among Caucasians. The results suggest that S2-M2 chromosomes carry HTG susceptibility sequences that predate the separation of the Asian and Caucasian races.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705829     DOI: 10.1007/bf00208957

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Apolipoprotein C-II and C-III levels in hyperlipoproteinemia.

Authors:  G Schonfeld; P K George; J Miller; P Reilly; J Witztum
Journal:  Metabolism       Date:  1979-10       Impact factor: 8.694

2.  Linkage disequilibrium in the human insulin/insulin-like growth factor II region of human chromosome II.

Authors:  N J Cox; G I Bell; K S Xiang
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

3.  Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population.

Authors:  A Rees; J Stocks; H Paul; Y Ohuchi; D Galton
Journal:  Hum Genet       Date:  1986-02       Impact factor: 4.132

4.  DNA polymorphic patterns and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in different ethnic groups.

Authors:  H Paul; D Galton; J Stocks
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

5.  Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

Authors:  D E Wilson; M Emi; P H Iverius; A Hata; L L Wu; E Hillas; R R Williams; J M Lalouel
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.

Authors:  J M Ordovas; F Civeira; J Genest; S Craig; A H Robbins; T Meade; M Pocovi; P M Frossard; U Masharani; P W Wilson
Journal:  Atherosclerosis       Date:  1991-03       Impact factor: 5.162

7.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

8.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

9.  Human apolipoprotein A-I and C-III genes reside in the p11----q13 region of chromosome 11.

Authors:  S W Law; G Gray; H B Brewer; A Y Sakaguchi; S L Naylor
Journal:  Biochem Biophys Res Commun       Date:  1984-02-14       Impact factor: 3.575

10.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Authors:  C S Wang; W J McConathy; H U Kloer; P Alaupovic
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more
  15 in total

1.  The apolipoprotein CIII T2854G variants are associated with postprandial triacylglycerol concentrations in normolipidemic Korean men.

Authors:  Sang-Koo Woo; Hyun-Sik Kang
Journal:  J Hum Genet       Date:  2003-09-27       Impact factor: 3.172

2.  Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

Authors:  M A Austin; P J Talmud; L A Luong; L Haddad; I N Day; B Newman; K L Edwards; R M Krauss; S E Humphries
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Study of apolipoproteinc3 Sstl polymorphism in healthy volunteers from Northern India.

Authors:  S Chhabra; D P Agarwal; S Vasisht; K Luthra; R Narang; S C Manchanda; L M Srivastava; N Das
Journal:  Indian J Clin Biochem       Date:  2003-07

4.  Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians.

Authors:  Aparna A Bhanushali; Bibhu R Das
Journal:  J Community Genet       Date:  2010-10-17

5.  Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Authors:  W W Li; M M Dammerman; J D Smith; S Metzger; J L Breslow; T Leff
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

7.  Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

Authors:  Michael Olivier; Xujing Wang; Regina Cole; Brian Gau; Jessica Kim; Edward M Rubin; Len A Pennacchio
Journal:  Genomics       Date:  2004-05       Impact factor: 5.736

8.  Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Authors:  Humaira Rasheed; Amanda J Phipps-Green; Ruth Topless; Malcolm D Smith; Catherine Hill; Susan Lester; Maureen Rischmueller; Matthijs Janssen; Timothy L Jansen; Leo A Joosten; Timothy R Radstake; Philip L Riches; Anne-Kathrin Tausche; Frederic Lioté; Alexander So; Andre van Rij; Gregory T Jones; Sally P McCormick; Andrew A Harrison; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Rheumatology (Oxford)       Date:  2016-04-18       Impact factor: 7.580

9.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

10.  Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms.

Authors:  Mahdi Garelnabi; Krithika Selvarajan; Dmitry Litvinov; Nalini Santanam; Sampath Parthasarathy
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.